AUS
NZ
UK
CA
USA
IND
Highlights:
- Coverage Termination: Over 6 million Australians are set to lose coverage at 38 private hospitals due to Healthscope's withdrawal from agreements with major health insurers, including Bupa and AHSA.
- Financial Dispute: The move highlights ongoing disputes over rising healthcare costs, with Healthscope citing inadequate funding as a key issue.
- Patient Impact: The termination affects patients already booked for procedures, leaving them with limited options such as changing insurers, hospitals, or incurring high out-of-pocket expenses.
Healthscope’s Decision to End Agreements
Healthscope, one of Australia’s largest private hospital operators, has announced it will terminate agreements with Bupa and 30 other funds represented by the Australian Health Services Alliance (AHSA). This decision, effective February 20 for Bupa members and March 4 for AHSA-affiliated funds, will leave over 6 million Australians without coverage at 38 private hospitals operated by the company.
The escalation stems from disagreements over funding and rising healthcare costs. Healthscope attributed the decision to a lack of viable funding options, citing attempts by insurers to challenge its introduction of out-of-pocket fees of up to $100 for some patients. The proposed fees were met with legal threats, prompting Healthscope to terminate its agreements.
Impact on Patients and Private Hospitals
Patients booked for surgeries and other procedures face uncertainty as they must choose between switching health funds, finding alternative hospitals, or bearing substantial out-of-pocket costs. Healthscope hospitals affected include major facilities across Sydney, such as Norwest, Prince of Wales, and Campbelltown private hospitals, and Melbourne sites like La Trobe and John Fawkner private hospitals.
The termination adds strain to an already challenged private healthcare sector. Rising costs, which increased by 5.7% over the past year, and financial pressures have halved profit margins for private hospitals in the five years leading to 2022, according to a federal government review.
Healthscope’s Stance on the Viability Crisis
Greg Horan, Chief Executive of Healthscope, highlighted a broader viability crisis for private hospitals. He emphasized that rising operational costs and insufficient funding models have hindered investments in private healthcare. The company has actively campaigned for insurers to adjust their agreements to address these challenges.
Horan stated, "In an environment of rising costs and private hospital closures, it is unacceptable for insurers to fail their core purpose – funding the care of their members."
Criticism from Health Insurers
AHSA Chief Executive Andrew Sando criticized Healthscope’s decision, alleging that it prioritizes investor interests over patient care. He argued that the move undermines equitable and sustainable healthcare, accusing the Brookfield-owned operator of focusing on profits rather than public interest.
Broader Industry Challenges
The dispute sheds light on the financial health of Australia’s private healthcare system. Private hospitals have faced mounting challenges, including rising service costs and limited funding adjustments from insurers. The Australian Bureau of Statistics attributes a 6.7% rise in the cost of medical and hospital services to these issues.
Healthscope, owned by Canadian private equity firm Brookfield, has been vocal about the need for greater financial support. The company carries approximately $1.6 billion in debt following its acquisition in 2019.
Bottomline
The termination of agreements between Healthscope and major insurers, including Bupa and AHSA, represents a critical juncture for Australia’s private healthcare system. With rising costs and mounting financial pressures, the move underscores the need for structural reforms in the sector. Affected patients and stakeholders face significant challenges as they navigate the implications of this decision.
